Insights on Pharmaceuticals & Medical Products

Article

Expanding horizons for risk management in pharma

– With risks mounting, drugmakers can take a page from other highly regulated, capital-intensive businesses.
Interview

Operations as a competitive advantage in biotechnology

– Esteban Santos, executive vice president for operations at Amgen, explains how the company is using operations to support innovation.
Interview

Collaborating to address our global public health challenges

– Jaak Peeters, head of global public health at Johnson & Johnson, discusses the role pharma can play in addressing big challenges,... such as fighting diseases like HIV and tuberculosis.
Article

Real-world evidence: Driving a new drug development paradigm in oncology

– The potential for real-world evidence is expanding, particularly in oncology drug development. To compete, some companies are... investing in robust real-world data and analytic capabilities.
Article

How pharma manufacturers can enhance their medical information teams

– Medical information teams can be a source of differentiation if used strategically. But the evolving environment means pharma... manufacturers will need to make organizational enhancements to get ahead.

Special Collections

Biopharma Frontiers:
What the future holds for the industry

Industry leaders and key stakeholders offer perspectives to inspire discussion and constructive debate.

The pharma launchpad

Ideas for pharma and biotech looking to invest for launch success.

Spotlight on Japan

As the world’s second-largest pharma and medtech market, Japan has historically been an innovation center for the industry.... But amid an evolving healthcare landscape, this collection of articles and interviews looks at what opportunities and challenges executives at life-sciences companies need to address.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

More insights

Article

Pursuing breakthroughs in cancer-drug development

– Here’s how to get the right medicines to the right patients faster.
Article

How pharma can accelerate business impact from advanced analytics

– Savvy pharma companies follow these five principles to scale analytics and improve their bottom line.
Article

Delivering growth: M&A in medical technology

– Medical-technology companies continue to rely on M&A for growth. How solid is your approach?
Article

Digital in R&D: The $100 billion opportunity

– Digital promises to transform R&D productivity over the next decade. What will it take to realize this potential?
Article

The medtech opportunity for Japanese companies

– A large-scale commitment to growth in healthcare technologies could be a key contributor to the Japanese economy.
Article

How medical-device CEOs can navigate digital disruption in healthcare

– Medical-device companies will need to reinvent themselves to stay competitive. Now’s the time to craft a strategy and scale... a transformation.
Commentary

Innovating at the speed of the 21st century in pharmaceuticals

– The CEO of Eli Lilly offers perspectives on accelerating change in the industry.
Article

Elevating the impact of medical affairs in Japan

– Recent research sheds light on the value of the medical channel and what it takes to have a high-performing medical-affairs organization.
Article

Innovative pharma contracts: When do value-based arrangements work?

– Many are exploring alternatives to traditional ‘per pill’ arrangements underlying reimbursement. This holds implications for pharma... manufacturers.
Article

Biopharma valuations—onward and upward?

– Companies focused on biopharma have done well in capital markets. A closer look at performance helps explain why.
Interview

What’s next for pharma innovation in China

– Three prominent Chinese executives discuss the progress of local companies in drug innovation and the evolving regulatory environment.
Article

The growth imperative for medical-device companies

– Recent valuations have been driven by high expectations of growth. Can your company deliver?
Article

Get more from your pharma commercial spend using advanced analytics

– Predictive analytics and data visualization offer pharma business leaders the opportunity to transform commercial-spend optimization... and lift returns by 10 to 25 percent.
Article

A 360-degree approach to patient adherence

– When patients don’t follow treatment regimens, outcomes worsen and costs rise. An insights-driven approach can help.
Interview

Why innovative products aren’t enough for a successful pharma launch

– In a tough launch environment, four executives share insights on how to set your company apart—with a laser focus on patients,... an agile approach, and an engaged organization.
Video

Building trust-based relationships in pharma

– Belén Garijo, member of the executive board of Merck and CEO of Merck Healthcare, touches on the industry’s outlook... and how her company is positioning itself for the future.
Sorry, we couldn't find any results. Try removing some filters.

Connect with our Pharmaceuticals & Medical Products Practice